HighTower Advisors
CMLTU

HighTower Advisors’s CM Life Sciences III Inc. Unit CMLTU Stock Holding History

HighTower Advisors’s Portfolio CMLTU Stock Details CMLTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-10,100
Closed -$104K – 3582
2021
Q3 		$104K Sell
10,100
-2,532
-20% -$26.4K ﹤0.01% 2844
2021
Q2 		$138K Buy
+12,632
New +$136K ﹤0.01% 2744

HighTower Advisors's CMLTU Position: Q4 2021 in Review

HighTower Advisors sold out of CM Life Sciences III Inc. Unit (CMLTU) in Q4 2021, closing a stake of 10,100 shares — an estimated $104K sold.

HighTower Advisors first reported a position in CMLTU in Q2 2021 and held it in 2 quarters. The position peaked at $138K in Q2 2021. 0 funds tracked by Wall St. Rank hold CMLTU as of Q4 2021.

  • HighTower Advisors reported no remaining CM Life Sciences III Inc. Unit position as of Q4 2021 after selling out during the quarter.
  • HighTower Advisors sold 10,100 CM Life Sciences III Inc. Unit shares in Q4 2021, an estimated $104K.
  • HighTower Advisors first reported a position in CM Life Sciences III Inc. Unit in Q2 2021 and held it in 2 quarters.
  • HighTower Advisors's CM Life Sciences III Inc. Unit position peaked at $138K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held CM Life Sciences III Inc. Unit as of Q4 2021.

Based on HighTower Advisors's 13F filing for Q4 2021, filed 10 Feb 2022.